PubRank

J G M Klijn

Author PubWeight™ 37.10‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial. Lancet 2002 14.06
2 Cancer risks in BRCA2 families: estimates for sites other than breast and ovary. J Med Genet 2005 2.65
3 Tumour characteristics, survival and prognostic factors of hereditary breast cancer from BRCA2-, BRCA1- and non-BRCA1/2 families as compared to sporadic breast cancer cases. Eur J Cancer 2007 1.58
4 Ipsilateral breast tumour recurrence in hereditary breast cancer following breast-conserving therapy. Eur J Cancer 2004 1.52
5 Tumour characteristics and prognosis of breast cancer patients carrying the germline CHEK2*1100delC variant. J Med Genet 2004 1.39
6 Survival and prognostic factors in BRCA1-associated breast cancer. Ann Oncol 2005 1.20
7 Family system characteristics and psychological adjustment to cancer susceptibility genetic testing: a prospective study. Clin Genet 2007 1.16
8 Laser microdissection and microarray analysis of breast tumors reveal ER-alpha related genes and pathways. Oncogene 2006 1.15
9 Allelotype of 28 human breast cancer cell lines and xenografts. Br J Cancer 2003 1.06
10 Experience of parental cancer in childhood is a risk factor for psychological distress during genetic cancer susceptibility testing. Ann Oncol 2006 0.96
11 Impact of screening for breast cancer in high-risk women on health-related quality of life. Br J Cancer 2004 0.92
12 Genetic testing in hereditary non-polyposis colorectal cancer families with a MSH2, MLH1, or MSH6 mutation. J Med Genet 2002 0.91
13 The course of distress in women at increased risk of breast and ovarian cancer due to an (identified) genetic susceptibility who opt for prophylactic mastectomy and/or salpingo-oophorectomy. Eur J Cancer 2006 0.91
14 Elevated expression of polymorphonuclear leukocyte elastase in breast cancer tissue is associated with tamoxifen failure in patients with advanced disease. Br J Cancer 2003 0.89
15 Tumor characteristics and detection method in the MRISC screening program for the early detection of hereditary breast cancer. Breast Cancer Res Treat 2006 0.87
16 Association between the CHEK2*1100delC germ line mutation and estrogen receptor status. Int J Gynecol Cancer 2006 0.86
17 Passive coping and psychological distress in women adhering to regular breast cancer surveillance. Psychooncology 2007 0.84
18 Clinical experience of prophylactic mastectomy followed by immediate breast reconstruction in women at hereditary risk of breast cancer (HB(O)C) or a proven BRCA1 and BRCA2 germ-line mutation. Eur J Surg Oncol 2002 0.84
19 Who is prone to high levels of distress after prophylactic mastectomy and/or salpingo-ovariectomy? Ann Oncol 2007 0.82
20 Possible consequences of applying guidelines to healthy women with a family history of breast cancer. Eur J Hum Genet 2003 0.80
21 Effect of combination therapy with aminoglutethimide and hydrocortisone on prostate-specific antigen response in metastatic prostate cancer refractory to standard endocrine therapy. Anticancer Drugs 2004 0.79
22 Effects of tamoxifen and octreotide LAR on the IGF-system compared with tamoxifen monotherapy. Eur J Cancer 2005 0.77
23 [Preventive surgical prcedures for inherited risk of breast cancer]. Ned Tijdschr Geneeskd 2005 0.76